<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01307553</url>
  </required_header>
  <id_info>
    <org_study_id>Sleeve III</org_study_id>
    <nct_id>NCT01307553</nct_id>
  </id_info>
  <brief_title>Over and Under/Aneugraft Pericardium Covered Stent Long Term Follow up Registry</brief_title>
  <acronym>Sleeve III</acronym>
  <official_title>OVER AND UNDER/ANEUGRAFT PERICARDIUM COVERED STENT Long Term Follow Up Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ITGI Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ITGI Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to track the clinical safety and effectiveness of the
      Pericardium Covered Stent in &quot;real world&quot; use.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a multi-center registry of 75 patients treated with the Over and Under/Aneugraft
      Pericardium Covered Stent (PCS) (IGTI, Israel). The registry will involve the collection of
      demographic, clinical, and angiographic data on the treated patient population, including
      in-hospital, 30 day, 6-month, 1 year, 2 years and 3 years clinical follow-up data.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2010</start_date>
  <completion_date type="Anticipated">April 2015</completion_date>
  <primary_completion_date type="Anticipated">October 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>MACE (Major Adverse Clinical Events)</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>MACE</measure>
    <time_frame>30 days, 1 Year, 2 Years, 3 Years</time_frame>
    <description>MACE is a composite end point of cardiac death, myocardial infarction and target vessel revascularisation (TVR).
Each one of the MACE components will be recorded separately</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital readmission due to cardiac reason.</measure>
    <time_frame>30 days, 6 months. 1 Year, 2 Years, 3 Years</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Diseased Saphenous Vein Grafts</condition>
  <condition>Aneurysmal Coronary Arteries</condition>
  <arm_group>
    <arm_group_label>PCS Group</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pericardium Covered Stent</intervention_name>
    <description>Percutaneous implantation of pericardium covered stent</description>
    <arm_group_label>PCS Group</arm_group_label>
    <other_name>Over and Under</other_name>
    <other_name>Aneugraft</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients presenting for PCI.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient is older than 18 years

          -  Patient must be available for follow-up

          -  Patient must be fully informed, provided with the patient information sheet and sign
             the Informed Consent Form prior to the procedure.

          -  The lesion to be treated should be suitable for treatment with a PCS in that:

               -  A. A suitable length and diameter PCS should be available

               -  B. For SVG disease a single or multiple PCS may be used

               -  C. For native coronary artery aneurysms the operator should be confident that the
                  aneurysm may be excluded by the implantation of a single PCS

        Exclusion Criteria:

          -  Significant co-morbidity precluding clinical follow-up.

          -  Pregnancy; pregnancy test negative in women with child bearing potential

          -  Acute ST-elevation myocardial infarction within the preceding 48 hours

          -  Previous stent implantation in the target vessel

          -  Left main coronary artery disease

          -  Contra-indication to dual anti-platelet therapy.

          -  Planned surgery which will lead to discontinuation of antiplatelet therapy

          -  Thrombocytopenia (&lt;100,000/mm3)

          -  Ejection fraction &lt;30%.

          -  Renal failure (creatinine &gt;180 µmol/L [2 mg/dL])

          -  Prior brachytherapy

          -  Recipient of heart transplant

          -  Acute infections
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Asif Qasim</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kings College Hospital, London</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Morris Mosseri, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sapir Health Center, Cfar Saba, Israel</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Matthew Lewis, MD</last_name>
    <phone>+972722200338</phone>
    <email>matthewl@itgimedical.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Shimon Lobel</last_name>
    <phone>+972722200351</phone>
    <email>shimonl@itgimedical.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sapir Health Center</name>
      <address>
        <city>Cfar Saba</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Morris Mosseri, MD</last_name>
      <email>morris.mosseri@clalit.org.il</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kings College Hospital</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Asif Qasim, MA PhD MRCP</last_name>
      <email>asif@g-cardio.net</email>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
    <country>United Kingdom</country>
  </location_countries>
  <reference>
    <citation>Siregar S, Hoseyni Guyomi S, van Herwerden LA. Covered stents in giant coronary artery aneurysm. Eur Heart J. 2010 Nov;31(22):2823. doi: 10.1093/eurheartj/ehq267. Epub 2010 Jul 30.</citation>
    <PMID>20675659</PMID>
  </reference>
  <reference>
    <citation>Malkin C, Gunn J. A big cover-up. Heart. 2009 Aug;95(16):1354. doi: 10.1136/hrt.2009.171843.</citation>
    <PMID>19638513</PMID>
  </reference>
  <reference>
    <citation>Wykrzykowska JJ, Gutiérrez-Chico JL, van Geuns RJ. &quot;Over-and-under&quot; pericardial covered stent with paclitaxel balloon in a saphenous vein graft. Catheter Cardiovasc Interv. 2010 May 1;75(6):964-6. doi: 10.1002/ccd.22412.</citation>
    <PMID>20432403</PMID>
  </reference>
  <reference>
    <citation>Tyczynski P, Kukreja N, van Geuns RJ, Wykrzykowska JJ, Sheppard MN, Di Mario C. Optical coherence tomography for the assessment of pericardium covered stents for the treatment of degenerated saphenous vein grafts. EuroIntervention. 2010 May;6(1):78-85. doi: 10.4244/.</citation>
    <PMID>20542801</PMID>
  </reference>
  <reference>
    <citation>Jokhi PP, McKenzie DB, O'Kane P. Use of a novel pericardial covered stent to seal an iatrogenic coronary perforation. J Invasive Cardiol. 2009 Oct;21(10):E187-90.</citation>
    <PMID>19805849</PMID>
  </reference>
  <reference>
    <citation>Hayat SA, Ghani S, More RS. Treatment of ruptured coronary aneurysm with a novel covered stent. Catheter Cardiovasc Interv. 2009 Aug 1;74(2):367-70. doi: 10.1002/ccd.21937.</citation>
    <PMID>19642186</PMID>
  </reference>
  <reference>
    <citation>Colombo A, Almagor Y, Gaspar J, Vonderwalde C. The pericardium covered stent (PCS). EuroIntervention. 2009 Aug;5(3):394-9. Review.</citation>
    <PMID>19736166</PMID>
  </reference>
  <reference>
    <citation>Heper G, Barcin C, Iyisoy A, Tore HF. Treatment of an iatrogenic left internal mammary artery to pulmonary artery fistula with a bovine pericardium covered stent. Cardiovasc Intervent Radiol. 2006 Sep-Oct;29(5):879-82.</citation>
    <PMID>16736101</PMID>
  </reference>
  <reference>
    <citation>Gaspar J, Martínez-Ríos MA, Vonderwalde C, Rosas M, Ban-Hayashi E, Eidt-Lidt G, Kuri J. Pericardium-covered stent for septal myocardial ablation in hypertrophic obstructive cardiomyopathy. Catheter Cardiovasc Interv. 1999 May;47(1):73-9.</citation>
    <PMID>10385166</PMID>
  </reference>
  <reference>
    <citation>Gaspar J, Vonderwalde C, Hong MK, Eid-Lidt G, Almagor Y, León MB. [Stent coated with bovine pericardium: in vitro evaluation, in animals, and initial results in humans]. Arch Cardiol Mex. 2001 Oct-Dec;71(4):286-94. Spanish.</citation>
    <PMID>11806031</PMID>
  </reference>
  <reference>
    <citation>Gaspar J, Vonderwalde C, Eid-Lidt G. Treatment of coronary artery aneurysms by percutaneous sealing with bovine-pericardium-covered stents. Int J Cardiovasc Intervent. 1999;2(4):241-246.</citation>
    <PMID>12623575</PMID>
  </reference>
  <results_reference>
    <citation>Ferlini M, Russo F, Marinoni B, Repetto A, Canosi U, Ferrario M, Visconti LO, Bramucci E. Images in cardiology. Percutaneous coronary aneurysm obliteration using a novel pericardium-covered stent. J Am Coll Cardiol. 2010 Dec 14;56(25):2139. doi: 10.1016/j.jacc.2010.04.071.</citation>
    <PMID>21144975</PMID>
  </results_reference>
  <verification_date>March 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 1, 2011</study_first_submitted>
  <study_first_submitted_qc>March 1, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 3, 2011</study_first_posted>
  <last_update_submitted>March 1, 2011</last_update_submitted>
  <last_update_submitted_qc>March 1, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 3, 2011</last_update_posted>
  <responsible_party>
    <name_title>VP Medical Affairs</name_title>
    <organization>ITGI Medical</organization>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

